WealthShield Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
WealthShield Partners's IBB Position: Q2 2026 in Review
WealthShield Partners sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 44 shares — an estimated $7.43K sold.
WealthShield Partners first reported a position in IBB in Q4 2017 and held it in 20 quarters. The position peaked at $90.1K in Q4 2023. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- WealthShield Partners reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
- WealthShield Partners sold 44 iShares Biotechnology ETF shares in Q2 2026, an estimated $7.43K.
- WealthShield Partners first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 20 quarters.
- WealthShield Partners's iShares Biotechnology ETF position peaked at $90.1K in Q4 2023.
- 957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on WealthShield Partners's 13F filing for Q2 2026, filed 12 Aug 2026.